| | Report | Presentation | Webcast |
|
December 9, 2020Interim Report May – October 2020 – Report
|
|
|
|
|
December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
| |
| |
|
November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference
| |
| |
|
October 29, 2020BIO-Europe®, Virtual Conference
| |
| |
|
October 7, 2020Oasmia Erik Penser Cancer Day Presentation
| |
| |
|
September 24, 2020Oasmia Erik Penser Investor Event Presentation
| |
|
|
|
September 21, 2020Presentation at Sachs Biotech in Europe Forum
| |
|
|
|
September 15, 2020Aktiedagen Digitalt
| |
|
|
|
September 9, 2020Interim Report May – July 2020
|
|
|
|
|
August 19, 2020Annual Report 2019 / 2020
|
| | |
|
July 30, 2020Analysguiden: Interview with Oasmia
| | |
|
|
June 18, 2020Year-end Report 2019 / 2020
|
|
|
|
|
June 10, 2020Company Presentation Aktiespararna
| |
|
|
|
June 3, 2020Avanza Börsdag
| |
|
|
|
May 13, 2020Strategic Review Presentation
| |
|
|
|
March 27, 2020Interim Report May 2019 – January 2020
|
| |
|
|
March 25, 2020Elevar deal
| | |
|
|
February 14, 2020Oasmia appoints new CEO
| | | |
